Publicado el boletín HIV This Week No. 97
Este boletín es publicado por el Programa Conjunto de las Naciones Unidas Sobre el Sida, ONUSIDA. Los editores y especialistas de ese espacio realizan una exploración selectiva de información relacionada con el VIH publicada en revistas científicas. Luego interpretan los resúmenes originales y proporcionan un comentario, que no representa ninguna declaración oficial de ONUSIDA, pero promueve el debate y el análisis profesional sobre el tema. En idioma inglés. Puede suscribirse para recibirlo por correo electrónico.
En esta ocasión, puede acceder a los comentarios en inglés de los siguientes temas:
1. Gender based violence
- Gender inequality norms, rape, and HIV risk: high time for legislative change in Botswana and Swaziland
- Pro wife-beating attitudes are a red flag identifying men trapped in maladaptive masculinities in Rwanda
2. Economics
- Streams of economic benefits offset treatment costs in low- and middle-income countries and generate excellent returns on investment
3. Microbicides
- Everything you need to know in the lead up to the Microbicides 2012 conference in Australia
4. Post-exposure prophylaxis
- Guidelines for PEPSE (PEP following Sexual Exposure) in the United Kingdom
5. Basic science
- The fascinating origins of the HIV pandemic
6. Injecting Drug Use
- Women who inject drugs at modestly higher HIV risk than men in high HIV prevalence settings
- Implications of ecological evidence of reduced ‘community viral load’ following antiretroviral treatment roll-out to people who inject drugs
7. Epidemiology
- Couple serodiscordancy patterns in sub-Saharan Africa can inform prevention programming
- Adjusted BED estimates: can mathematics really make HIV incidence determination simpler?
8. Treatment
- Early mortality (death in the first year of antiretroviral treatment) is highest in sub-Saharan Africa, followed by Asia, and the Americas
9. Non-subtype B infection
- Subtype A is the least aggressive: could subtyping play a role in clinical management in the future?
- Would CCR5 antagonists like maraviroc work in India, Uganda, and South Africa: which co-receptor (CCR5, CXCR4) are non-subtype B viruses attracted to (tropism)?
10. Pre-exposure prophylaxis
- What would happen to HIV transmission and drug resistance in Botswana if pre-exposure prophylaxis programmes were introduced?
11. Research conduct
- Challenges posed by non-inferiority designs for trials of new HIV prevention technologies
- Good practice case study of knowledge translation and exchange (KTE) with adolescent survey participants in South Africa
12. Health care delivery
- Listening to health care workers: ideas on how to improve PMTCT services in Uganda
- How competing risk of death affects estimates of loss to follow-up in antiretroviral treatment programmes in Zambia and Switzerland
13. Adolescents
- Adolescents at a Cape Town community-based antiretroviral therapy clinic have better immune responses despite less virus suppression
- Low levels of HIV knowledge among street adolescents in rehab centres in Kinshasa
14. Preventing new paediatric infections
- Quality of antenatal care also affects PMTCT coverage in the PEARL study in Cameroon, Cote d’Ivoire, South Africa and Zambia
- The weak link in preventing paediatric infection: HIV acquisition during pregnancy and breastfeeding and what can be done about it.